{
  "schema_version": "0.1.0",
  "case_id": "HR-ML050",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML050",
    "display_name": "Duke Kahanamoku",
    "aliases": [
      "Duke Paoa Kahino Makoe Hulikohoa Kahanamoku"
    ],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "Native Hawaiian (American)",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1890-08-24",
          "display": "August 24, 1890",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1890",
              "display": "1890",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0010"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with PBS, the Star-Advertiser and Olympedia."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1968-01-22",
          "display": "January 22, 1968",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1968",
              "display": "1968",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0010"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML050-SYN",
      "ssn": "000-50-6847",
      "date_of_birth": "1959-08-24",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Kawika Lindgren-Morrison, MD",
      "fictional_consultant": {
        "name": "Noelani Abernathy-Chen, MD",
        "specialty": "Cardiology (heart failure)"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1890-08-24",
        "display": "August 24, 1890",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Honolulu.",
      "claim_ids": [
        "CLM-0001",
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1911",
        "display": "1911",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Co-founds the Hui Nalu surf club.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1912",
        "display": "1912",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Olympic champion in the 100-meter freestyle at Stockholm.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1914-12-24",
        "display": "December 24, 1914",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Surfing exhibition at Freshwater Beach, Sydney.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1920",
        "display": "1920",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Two Olympic gold medals at Antwerp.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1922",
        "display": "1922",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Moves to Los Angeles and acts in films.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1934",
        "display": "1934 (1932 in some sources)",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "First elected sheriff of Honolulu.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1940-08-02",
        "display": "August 2, 1940",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Marries Nadine Alexander in Kailua-Kona.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1952",
        "display": "1952",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Heart attack.",
      "claim_ids": [
        "CLM-0009",
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1956",
        "display": "1956",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Official U.S. representative at the Melbourne Olympic Games.",
      "claim_ids": [
        "CLM-0014",
        "CLM-0013"
      ]
    },
    {
      "event_id": "EVT-0011",
      "date": {
        "iso": "1962",
        "display": "1962",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Cerebral blood clot; survives a brain operation.",
      "claim_ids": [
        "CLM-0010"
      ]
    },
    {
      "event_id": "EVT-0012",
      "date": {
        "iso": "1968-01-22",
        "display": "January 22, 1968",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies of a heart attack in Honolulu.",
      "claim_ids": [
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0013",
      "date": {
        "iso": "1968-01-27",
        "display": "January 27, 1968",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Beachboy funeral at Waikīkī.",
      "claim_ids": [
        "CLM-0012"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Duke Kahanamoku was born on August 24, 1890, in Honolulu, at Haleʻākala, the Honolulu home of Princess Bernice Pauahi Bishop; he was named after his father, who had been named Duke for a visit of the Duke of Edinburgh to Hawaiʻi.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the true birth date and his Native Hawaiian heritage and home in Honolulu. One International Swimming Hall of Fame tribute implies an August 14 birthday through its arithmetic; the dated sources agree on August 24.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Duke Kahanamoku was born in Honolulu, Hawai'i on August 24, 1890"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Aug. 24, 1890: Born at Hale'akala, Honolulu home of Princess Bernice Pauahi Bishop"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Born: 24 August 1890 in Honolulu; named after the Duke of Edinburgh"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "Duke was named after his father, who was named after the Duke of Edinburgh, who visited Hawaii"
        },
        {
          "source_id": "SRC-0010",
          "relationship": "supports",
          "locator": "roster birth year 1890"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "Olympedia gives his full name as Duke Paoa Kahino Makoe Hulikohoa Kahanamoku.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Used only for the alias. Other spellings of the middle names exist; the brief's spelling (Kahinu Mokoe Hulikohola) was not found in a source that could be fetched.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Duke Paoa Kahino Makoe Hulikohoa Kahanamoku"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "He won the Olympic 100-meter freestyle in 1912 at Stockholm (with silver in the 4 x 200-meter relay) and again in 1920 at Antwerp (with gold in the relay), and silver in the 100-meter freestyle in 1924 at Paris: three gold and two silver medals.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors his identity as a lifelong swimmer in the modern social history and the adapted exercise plan.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1912 ... gold medal in the 100-meter freestyle; 1920 Kahanamoku wins gold medals in the 100-meter freestyle and the 4x200-meter freestyle relay; 1924 silver medal in the 100-meter freestyle"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "1912 100 metres Freestyle Gold; 4 x 200 Relay Silver; 1920 Gold, Gold; 1924 Silver"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "1912: Hawaii's first Olympian. Wins gold (100 free record) and silver (4x200 free relay)"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "1965 Honor Swimmer"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "He co-founded the Hui Nalu surf club in 1911, introduced surfing to the Atlantic coast of the United States in 1914 and gave a surfing exhibition at Freshwater Beach in Sydney on December 24, 1914, widely regarded as a seminal event for surfing in Australia; he was inducted into the International Swimming Hall of Fame in 1965 and was the first inductee of the International Surfing Hall of Fame in 1966.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors his identity as a surfer and waterman in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "1911: Co-founds Hui Nalu Surf Club; Dec. 24, 1914: Gives surfing exhibition at Sydney's Freshwater Beach; 1965: Inducted into the International Swimming Hall of Fame. 1966: First inductee in the International Surfing Hall of Fame"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1914: Kahanamoku introduces surfing to the U.S. Atlantic coast"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "the first athlete to be inducted into the International Halls of Fame for swimming and surfing"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "From 1922 he lived in Los Angeles for years and found small roles in many Hollywood films.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1922: Duke Kahanamoku resides in Los Angeles and spends years pursuing an acting career"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "He was elected sheriff of Honolulu for 13 consecutive terms, from 1934 until the post was eliminated in 1960, after which he was named Hawaiʻi's \"Ambassador of Aloha\"; other sources date his first election to 1932 and his departure to 1961.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Anchors his occupation at the index date (1957). The Star-Advertiser and PBS give 1934 to 1960; Olympedia, the Encyclopedia of World Biography and EBSCO give 1932 to 1961. Either way he was sheriff in 1957.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "1934-1960: Elected for 13 consecutive terms as sheriff of Honolulu; 1960: Appointed 'Ambassador of Aloha'"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1934: Appointed Sheriff of Honolulu, Hawaii for the first time"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "disputes",
          "locator": "Sheriff of Honolulu from 1932-61"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "disputes",
          "locator": "In 1932, he ran unopposed for sheriff; When he left his sheriff's post in 1961"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "He married Nadine Alexander on August 2, 1940, in Kailua-Kona.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Documented history only; his wife is not given any role, statement or health fact in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Aug. 2, 1940: Marries Nadine Alexander in Kailua-Kona"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1940: Kahanamoku marries Nadine Alexander"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "He never drank alcohol or smoked and trained consistently.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the substance history in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "He never drank or smoked, rarely fought, and trained consistently"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "He took good care of his body, never smoking or drinking and training consistently"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "He had a heart attack in 1952 and suffered several heart attacks in his later years, continuing to swim and sail almost to the end of his life.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The documented anchor for the old myocardial infarction in the modern episode. The year 1952 rests on the Honolulu Star-Advertiser alone; EBSCO says he had several heart attacks without dates. A heart attack in 1955, named in the brief, was not found in any source read and is not used.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Kahanamoku had previous medical incidents, including a heart attack in 1952 and a cerebral blood clot in 1962"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "even after he suffered several heart attacks and had survived a brain operation"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "In 1962 he had a cerebral blood clot and survived a brain operation.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Later history, after the modern episode. The Star-Advertiser names a cerebral blood clot in 1962 and EBSCO an undated brain operation; a 1962 wire report of an operation for a blood clot on the brain at Kaiser Hospital, found in a search, could not be fetched. No source read describes a tumor.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "a cerebral blood clot in 1962"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "had survived a brain operation"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "On January 22, 1968, he collapsed with a heart attack at the Waikiki Yacht Club while working on his boat, was taken to Kaiser Foundation Hospital and died there, aged 77.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The cause of death, a heart attack, fits the long course of coronary disease taught in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Jan. 22, 1968: Dies in Honolulu after suffering heart attack at Waikiki Yacht Club"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "January 22, 1968: Duke Kahanamoku dies of a heart attack at age 77"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "Duke collapsed at the Waikiki Yacht Club and was rushed to Kaiser Foundation Hospital, where he died"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Died: 22 January 1968 in Honolulu (aged 77)"
        },
        {
          "source_id": "SRC-0010",
          "relationship": "supports",
          "locator": "roster death year 1968"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0012",
      "statement": "On January 27, 1968, his ashes were scattered off Waikīkī in a beachboy funeral attended by thousands.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after his death.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Jan. 27, 1968: Ashes scattered off 'First Break' in beachboy funeral attended by thousands on Waikiki Beach"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0013",
      "statement": "He had no great personal wealth.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors his modest means in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "He had no great personal wealth, no political clout"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0014",
      "statement": "He was the official United States representative at the 1956 Melbourne Olympic Games.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors his continuing role in sport at the index date.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "1956: Duke Kahanamoku is the official U.S. representative at the Melbourne Olympics"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Duke Kahanamoku: biography and life timeline. American Masters",
      "publisher": "PBS (WNET)",
      "url": "https://www.pbs.org/wnet/americanmasters/duke-kahanamoku-biography-and-life-timeline/21754",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "Public broadcaster timeline; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Luis C. A wonderful life (Duke Kahanamoku timeline). Honolulu Star-Advertiser, January 22, 2018",
      "publisher": "Honolulu Star-Advertiser",
      "url": "https://staradvertiser.com/?p=715741",
      "source_type": "other",
      "published": "2018-01-22",
      "accessed": "2026-11-06",
      "rights_note": "Newspaper timeline published on the 50th anniversary of his death; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Luis C. Legacy of Hawaii's most beloved, honored athlete endures 50 years after his death. Honolulu Star-Advertiser, January 22, 2018",
      "publisher": "Honolulu Star-Advertiser",
      "url": "https://staradvertiser.com/?p=715743",
      "source_type": "other",
      "published": "2018-01-22",
      "accessed": "2026-11-06",
      "rights_note": "Newspaper article (the successor of the Star-Bulletin and the Advertiser); facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Duke Kahanamoku (athlete profile)",
      "publisher": "Olympedia (OlyMADMen)",
      "url": "https://www.olympedia.org/athletes/51429",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "Olympic historians' database; used for his full name, dates and medals."
    },
    {
      "source_id": "SRC-0005",
      "title": "Duke Kahanamoku. Research Starters: History",
      "publisher": "EBSCO",
      "url": "https://ebsco.com/research-starters/history/duke-kahanamoku",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "Reference summary; used for his heart attacks, the brain operation, his abstinence from tobacco and alcohol, and his death."
    },
    {
      "source_id": "SRC-0006",
      "title": "August 24: celebrate the birth of one of Hawaii's greatest sons and 1965 ISHOF Honoree, Duke Kahanamoku",
      "publisher": "International Swimming Hall of Fame",
      "url": "https://ishof.org/?p=2428",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "Hall of fame tribute; used for his induction and Olympic record."
    },
    {
      "source_id": "SRC-0007",
      "title": "Kahanamoku, Duke. Encyclopedia of World Biography",
      "publisher": "Gale, via Encyclopedia.com",
      "url": "https://www.encyclopedia.com/doc/1G2-3404707611.html",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-06",
      "rights_note": "Reference encyclopedia entry; used for his abstinence from tobacco and alcohol and the sheriff dates."
    },
    {
      "source_id": "SRC-0010",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-06",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-03-16",
    "index_age": 66,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Heart failure with reduced ejection fraction from ischemic cardiomyopathy in a 66-year-old Native Hawaiian man, sheriff of Honolulu and a lifelong Olympic swimmer and surfer, five years after a heart attack. The episode covers breathlessness, ankle swelling and tiredness diagnosed by NT-proBNP and echocardiography (ejection fraction 30%); invasive coronary angiography for the ischemic cause; the four pillars of guideline-directed medical therapy under the 2022 AHA/ACC/HFSA guideline and the 2024 ACC decision pathway: changing lisinopril to sacubitril-valsartan with a 36-hour washout, changing metoprolol tartrate to carvedilol, empagliflozin and spironolactone, titrated every two weeks with potassium, magnesium and kidney checks; a loop diuretic adjusted to euvolemia; intravenous iron for iron deficiency; sick-day rules when vomiting and diarrhea raise potassium and creatinine; a missed laboratory check recorded honestly; the decision against a primary-prevention defibrillator when the ejection fraction rose from 30% to 38% after more than 90 days of therapy; sodium guidance without routine fluid restriction; cardiac rehabilitation adapted to an ocean athlete, with swimming and surfing safety; vaccinations; and culturally safe care for a Native Hawaiian patient, with his ʻohana involved as he chooses, his own healing practices respected, and attention to the higher and earlier burden of heart failure hospitalization among Native Hawaiians.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-03-16",
        "purpose": "Establishing care for six weeks of breathlessness, ankle swelling and tiredness five years after a heart attack: examination, ECG, chest X-ray, NT-proBNP and laboratory tests, a diuretic, and the plan for an echocardiogram"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-03-30",
        "purpose": "Two-week review: echocardiogram, heart failure cardiology consultation the same day, the diagnosis, and guideline-directed medicines"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-04-13",
        "purpose": "Two-week review after sacubitril-valsartan, carvedilol and empagliflozin: kidney function, potassium, angiography result and the next medicine"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-04-22",
        "purpose": "Same-day sick visit for vomiting and diarrhea on heart failure medicines"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-04-27",
        "purpose": "Two-week review, five days after the sick visit: kidney function and potassium, medicine doses, lipids, and cardiac rehabilitation adapted to the ocean"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-09-14",
        "purpose": "Subsequent annual wellness visit"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-09-28",
        "purpose": "Six-month review: repeat echocardiogram after more than 90 days of therapy, the defibrillator decision, iron, the delayed titration step, and plans for the year"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Breathlessness on exertion for six weeks (paddling out, walking uphill, finishing his morning swim), with ankle swelling by evening and tiredness, five years after a heart attack; cause to be determined",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R06.09",
            "display": "Other forms of dyspnea",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic presenting problem, resolved at the second visit when the echocardiogram and cardiology established heart failure with reduced ejection fraction.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-03-30"
      },
      {
        "id": "PRB-002",
        "display": "Coronary artery disease with an old anterior myocardial infarction five years ago, treated with medicines; synthetic modern episode linked to the documented heart attack of 1952",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I25.2",
            "display": "Old myocardial infarction",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern diagnosis; the 1952 heart attack remains D in the history.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-003",
        "display": "Heart failure with reduced ejection fraction from ischemic cardiomyopathy (ejection fraction 30% with a thinned, akinetic anterior wall and apex), NYHA class III at diagnosis",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I50.22",
            "display": "Chronic systolic (congestive) heart failure",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern diagnosis made at the second visit; no claim that he had heart failure in his lifetime.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-03-30"
      },
      {
        "id": "PRB-004",
        "display": "Iron deficiency without anemia (ferritin 62 ng/mL, transferrin saturation 16%)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E61.1",
            "display": "Iron deficiency",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding at the heart failure workup.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-005",
        "display": "Viral gastroenteritis for two days, with volume depletion, potassium 5.5 mmol/L and a rise in creatinine on sacubitril-valsartan, spironolactone, empagliflozin and furosemide; settled with sick-day rules",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "A08.4",
            "display": "Viral intestinal infection, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic intercurrent problem at an unscheduled visit; it follows from his heart failure medicines and does not echo a documented illness.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-04-22"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Aspirin 81 mg delayed-release oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "308416",
            "display": "aspirin 81 MG Delayed Release Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2021-06-21",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic low-dose aspirin since the heart attack five years ago.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Atorvastatin 40 mg oral tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "617311",
            "display": "atorvastatin 40 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2021-06-21",
        "end_date": "2026-03-16",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic statin since the heart attack; replaced by the 80 mg tablet at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Atorvastatin 80 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "259255",
            "display": "atorvastatin 80 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-03-16",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic high-intensity statin for LDL 92 mg/dL above the secondary-prevention goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Metoprolol tartrate 25 mg oral tablet, one tablet twice daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "866924",
            "display": "metoprolol tartrate 25 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily"
        },
        "start_date": "2021-06-21",
        "end_date": "2026-03-30",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic beta-blocker since the heart attack; not one of the beta-blockers proven in heart failure, so replaced by carvedilol at the two-week visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Lisinopril 10 mg oral tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "314076",
            "display": "lisinopril 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2021-06-21",
        "end_date": "2026-03-30",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ACE inhibitor since the heart attack; stopped at the two-week visit, 36 hours before sacubitril-valsartan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Furosemide 40 mg oral tablet, one tablet every morning",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "313988",
            "display": "furosemide 40 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet every morning"
        },
        "start_date": "2026-03-16",
        "end_date": "2026-04-27",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic loop diuretic for congestion; reduced to 20 mg when he was euvolemic.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Furosemide 20 mg oral tablet, one tablet every morning",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "310429",
            "display": "furosemide 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet every morning"
        },
        "start_date": "2026-04-27",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lower diuretic dose once euvolemic.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Sacubitril 24 mg / valsartan 26 mg oral tablet, one tablet twice daily, first dose 36 hours after the last lisinopril",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1656340",
            "display": "sacubitril 24 MG / valsartan 26 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily"
        },
        "start_date": "2026-03-30",
        "end_date": "2026-09-28",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ARNI started 36 hours after the last ACE inhibitor dose; the planned increase two weeks after the fourth visit did not happen, and it was raised at the six-month visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Sacubitril 49 mg / valsartan 51 mg oral tablet, one tablet twice daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1656349",
            "display": "sacubitril 49 MG / valsartan 51 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily"
        },
        "start_date": "2026-09-28",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ARNI dose increase at the six-month visit, with a metabolic panel one to two weeks later.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-010",
        "display": "Carvedilol 3.125 mg oral tablet, one tablet twice daily with food, starting the evening after the last metoprolol tartrate",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "686924",
            "display": "carvedilol 3.125 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily with food"
        },
        "start_date": "2026-03-30",
        "end_date": "2026-04-13",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic evidence-based beta-blocker replacing metoprolol tartrate.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-011",
        "display": "Carvedilol 6.25 mg oral tablet, one tablet twice daily with food",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "200031",
            "display": "carvedilol 6.25 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily with food"
        },
        "start_date": "2026-04-13",
        "end_date": "2026-04-27",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic beta-blocker titration step.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-012",
        "display": "Carvedilol 12.5 mg oral tablet, one tablet twice daily with food",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "200032",
            "display": "carvedilol 12.5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily with food"
        },
        "start_date": "2026-04-27",
        "indication_problem_ids": [
          "PRB-003",
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic beta-blocker titration step; further increase limited by blood pressure and heart rate.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-013",
        "display": "Empagliflozin 10 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating or drinking",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1545658",
            "display": "empagliflozin 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily, with sick-day rules"
        },
        "start_date": "2026-03-30",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic SGLT2 inhibitor for heart failure with reduced ejection fraction.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-014",
        "display": "Spironolactone 25 mg oral tablet, one-half tablet (12.5 mg) daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "313096",
            "display": "spironolactone 25 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 0.5,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One-half tablet daily"
        },
        "start_date": "2026-04-13",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mineralocorticoid receptor antagonist started with potassium 4.5 mmol/L and eGFR above 30.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "MED-015",
        "display": "Ferric carboxymaltose 750 mg (15 mL vial, 50 mg/mL) by intravenous infusion, two doses two weeks apart",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1435169",
            "display": "15 ML ferric carboxymaltose 50 MG/ML Injection",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "intravenous",
        "frequency": {
          "period": 14,
          "period_unit": "d",
          "text": "Two infusions two weeks apart"
        },
        "start_date": "2026-03-30",
        "end_date": "2026-04-13",
        "indication_problem_ids": [
          "PRB-004",
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic intravenous iron for iron deficiency in heart failure with reduced ejection fraction; both doses given in the clinic.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-NTPROBNP-V1",
        "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
        "label": "NT-proBNP",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 2450,
        "unit": "pg/mL",
        "reference_range": {
          "high": 125,
          "text": "Below 125 pg/mL makes heart failure unlikely outside the hospital"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "33762-6",
            "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic NT-proBNP in an older man with breathlessness, ankle swelling and an old heart attack: high, so heart failure is likely and an echocardiogram is needed.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel and magnesium before a loop diuretic.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 4.2,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel and magnesium before a loop diuretic.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 1.02,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel and magnesium before a loop diuretic.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 81,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel and magnesium before a loop diuretic.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 102,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel and magnesium before a loop diuretic.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V1",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 2.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.6,
          "high": 2.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline metabolic panel and magnesium before a loop diuretic.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 13.4,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin; no anemia.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-FER-V1",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 62,
        "unit": "ng/mL",
        "reference_range": {
          "low": 100,
          "high": 400,
          "text": "In heart failure, below 100 ng/mL, or 100 to 299 with transferrin saturation below 20%, is iron deficiency"
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ferritin at the heart failure workup: below 100 ng/mL, iron deficiency without anemia.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSAT-V1",
        "display": "Iron saturation [Mass Fraction] in Serum or Plasma",
        "label": "Transferrin saturation",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 16,
        "unit": "%",
        "reference_range": {
          "low": 20,
          "high": 50
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2502-3",
            "display": "Iron saturation [Mass Fraction] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic transferrin saturation; low.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 2.1,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH at the heart failure workup; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 5.9,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin A1c in the prediabetes range.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 168,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 40 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 92,
        "unit": "mg/dL",
        "reference_range": {
          "high": 69,
          "text": "Secondary-prevention goal below 70 mg/dL"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 40 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 44,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 40 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 160,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel on atorvastatin 40 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-16",
        "value": 28,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ALT on atorvastatin; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-03-16",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-2; below the cut point of 3. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-KCCQ-V1",
        "display": "Overall summary score [KCCQ-12]",
        "label": "KCCQ-12 overall summary",
        "status": "final",
        "effective_date": "2026-03-16",
        "value": 38,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "86924-8",
            "display": "Overall summary score [KCCQ-12]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline heart failure health status: poor to fair.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V2",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting furosemide: potassium a little lower, creatinine up slightly, as expected.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V2",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 3.9,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting furosemide: potassium a little lower, creatinine up slightly, as expected.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 1.08,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting furosemide: potassium a little lower, creatinine up slightly, as expected.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 76,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting furosemide: potassium a little lower, creatinine up slightly, as expected.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V2",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 98,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting furosemide: potassium a little lower, creatinine up slightly, as expected.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V2",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-30",
        "value": 1.9,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.6,
          "high": 2.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel two weeks after starting furosemide: potassium a little lower, creatinine up slightly, as expected.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-LVEF-V2",
        "display": "Left ventricular Ejection fraction",
        "label": "LVEF by echocardiogram",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-30",
        "value": 30,
        "unit": "%",
        "reference_range": {
          "low": 50,
          "high": 70
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "10230-1",
            "display": "Left ventricular Ejection fraction",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic echocardiogram: reduced ejection fraction with an old anterior infarct.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V3",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel about two weeks after sacubitril-valsartan and empagliflozin were started: the expected small creatinine rise (about 7%); potassium in range.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V3",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 4.5,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel about two weeks after sacubitril-valsartan and empagliflozin were started: the expected small creatinine rise (about 7%); potassium in range.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 1.16,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel about two weeks after sacubitril-valsartan and empagliflozin were started: the expected small creatinine rise (about 7%); potassium in range.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 69,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel about two weeks after sacubitril-valsartan and empagliflozin were started: the expected small creatinine rise (about 7%); potassium in range.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V3",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 96,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel about two weeks after sacubitril-valsartan and empagliflozin were started: the expected small creatinine rise (about 7%); potassium in range.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V3",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 2.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.6,
          "high": 2.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel about two weeks after sacubitril-valsartan and empagliflozin were started: the expected small creatinine rise (about 7%); potassium in range.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-KCCQ-V3",
        "display": "Overall summary score [KCCQ-12]",
        "label": "KCCQ-12 overall summary",
        "status": "final",
        "effective_date": "2026-04-13",
        "value": 56,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "86924-8",
            "display": "Overall summary score [KCCQ-12]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic improvement in heart failure health status after decongestion.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V6",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 133,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "L",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on the second day of vomiting and diarrhea, nine days after spironolactone was added: potassium 5.5 mmol/L and creatinine up from 1.16 mg/dL, from volume depletion on four medicines that act on the kidney.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V6",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 5.5,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on the second day of vomiting and diarrhea, nine days after spironolactone was added: potassium 5.5 mmol/L and creatinine up from 1.16 mg/dL, from volume depletion on four medicines that act on the kidney.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V6",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 1.52,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on the second day of vomiting and diarrhea, nine days after spironolactone was added: potassium 5.5 mmol/L and creatinine up from 1.16 mg/dL, from volume depletion on four medicines that act on the kidney.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V6",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 50,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "L",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on the second day of vomiting and diarrhea, nine days after spironolactone was added: potassium 5.5 mmol/L and creatinine up from 1.16 mg/dL, from volume depletion on four medicines that act on the kidney.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V6",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 88,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on the second day of vomiting and diarrhea, nine days after spironolactone was added: potassium 5.5 mmol/L and creatinine up from 1.16 mg/dL, from volume depletion on four medicines that act on the kidney.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V6",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-22",
        "value": 2.1,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.6,
          "high": 2.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on the second day of vomiting and diarrhea, nine days after spironolactone was added: potassium 5.5 mmol/L and creatinine up from 1.16 mg/dL, from volume depletion on four medicines that act on the kidney.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel five days after the sick visit and two days after all medicines were restarted: potassium and creatinine back near baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 4.8,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel five days after the sick visit and two days after all medicines were restarted: potassium and creatinine back near baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 1.2,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel five days after the sick visit and two days after all medicines were restarted: potassium and creatinine back near baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 67,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel five days after the sick visit and two days after all medicines were restarted: potassium and creatinine back near baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 97,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel five days after the sick visit and two days after all medicines were restarted: potassium and creatinine back near baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V4",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 2.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.6,
          "high": 2.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel five days after the sick visit and two days after all medicines were restarted: potassium and creatinine back near baseline.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V4",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 130,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel six weeks after atorvastatin was raised to 80 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V4",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 62,
        "unit": "mg/dL",
        "reference_range": {
          "high": 69,
          "text": "Secondary-prevention goal below 70 mg/dL"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel six weeks after atorvastatin was raised to 80 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V4",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 45,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel six weeks after atorvastatin was raised to 80 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V4",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 115,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel six weeks after atorvastatin was raised to 80 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-27",
        "value": 31,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ALT on atorvastatin 80 mg; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-KCCQ-V4",
        "display": "Overall summary score [KCCQ-12]",
        "label": "KCCQ-12 overall summary",
        "status": "final",
        "effective_date": "2026-04-27",
        "value": 66,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "86924-8",
            "display": "Overall summary score [KCCQ-12]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic heart failure health status on titrated therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V7",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-09-14",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-2 at the annual wellness visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NTPROBNP-V5",
        "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
        "label": "NT-proBNP",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 620,
        "unit": "pg/mL",
        "reference_range": {
          "high": 125,
          "text": "Below 125 pg/mL makes heart failure unlikely outside the hospital"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "33762-6",
            "display": "Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic NT-proBNP after about five months of optimized therapy, for prognosis rather than titration; much lower but still raised.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at about six months; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at about six months; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 1.14,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at about six months; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 70,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at about six months; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V5",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 95,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at about six months; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MG-V5",
        "display": "Magnesium [Mass/volume] in Serum or Plasma",
        "label": "Magnesium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 2.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 1.6,
          "high": 2.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "19123-9",
            "display": "Magnesium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at about six months; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 14.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin after intravenous iron.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-FER-V5",
        "display": "Ferritin [Mass/volume] in Serum or Plasma",
        "label": "Ferritin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 248,
        "unit": "ng/mL",
        "reference_range": {
          "low": 100,
          "high": 400,
          "text": "In heart failure, below 100 ng/mL, or 100 to 299 with transferrin saturation below 20%, is iron deficiency"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2276-4",
            "display": "Ferritin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ferritin about six months after intravenous iron; replete.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSAT-V5",
        "display": "Iron saturation [Mass Fraction] in Serum or Plasma",
        "label": "Transferrin saturation",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-28",
        "value": 27,
        "unit": "%",
        "reference_range": {
          "low": 20,
          "high": 50
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2502-3",
            "display": "Iron saturation [Mass Fraction] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic transferrin saturation after intravenous iron; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-LVEF-V5",
        "display": "Left ventricular Ejection fraction",
        "label": "LVEF by echocardiogram",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-09-28",
        "value": 38,
        "unit": "%",
        "reference_range": {
          "low": 50,
          "high": 70
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "10230-1",
            "display": "Left ventricular Ejection fraction",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat echocardiogram after more than 90 days of optimized therapy: ejection fraction improved from 30% to 38%, above the 35% threshold for a primary-prevention defibrillator.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-KCCQ-V5",
        "display": "Overall summary score [KCCQ-12]",
        "label": "KCCQ-12 overall summary",
        "status": "final",
        "effective_date": "2026-09-28",
        "value": 80,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "86924-8",
            "display": "Overall summary score [KCCQ-12]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic heart failure health status at about six months.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MINICOG-V7",
        "display": "Total score [Mini-Cog]",
        "label": "Mini-Cog",
        "status": "final",
        "effective_date": "2026-09-14",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72233-0",
            "display": "Total score [Mini-Cog]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cognitive screen at the annual wellness visit (three-word recall 3 of 3, clock normal).",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V7",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-09-14",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen; he does not drink, as documented.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Twelve-lead electrocardiogram: sinus rhythm at 92 per minute, Q waves in V1 to V4 from an old anterior infarction, QRS 104 ms, no left bundle branch block, no atrial fibrillation",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-03-16",
          "end": "2026-03-16"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic baseline ECG at the heart failure workup.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Chest X-ray, two views: enlarged heart, upper-lobe venous diversion and small pleural effusions on both sides; no pneumonia",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "399208008",
            "display": "Plain X-ray of chest",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-03-16",
          "end": "2026-03-16"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic chest film at the heart failure workup.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Transthoracic echocardiography: ejection fraction 30% by biplane method, thinned and akinetic anterior wall and apex, no left ventricular thrombus, dilated left ventricle (end-diastolic diameter 62 mm), moderate functional mitral regurgitation, normal right ventricle, estimated pulmonary artery systolic pressure 42 mmHg",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "433236007",
            "display": "Transthoracic echocardiography",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-03-30",
          "end": "2026-03-30"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic diagnostic echocardiogram.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Invasive coronary angiography by the radial route: chronic total occlusion of the proximal left anterior descending artery filling faintly by collaterals from the right coronary artery, 40% narrowing of the mid right coronary artery and 30% of the circumflex; no lesion suitable for or likely to benefit from revascularization, given the thinned, scarred anterior wall",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "33367005",
            "display": "Angiography of coronary artery",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-04-06",
          "end": "2026-04-06"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ischemic evaluation of new heart failure with reduced ejection fraction.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Twelve-lead electrocardiogram at the sick visit: sinus rhythm at 96 per minute, old anterior Q waves unchanged, no peaked T waves, no change in QRS width",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-04-22",
          "end": "2026-04-22"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ECG for potassium 5.5 mmol/L.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Outpatient cardiac rehabilitation for heart failure: 36 sessions over twelve weeks, with supervised pool swimming in the last month and an ocean-safety plan; all sessions completed",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "395697009",
            "display": "Cardiac rehabilitation - phase 2",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-05-26",
          "end": "2026-08-14"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cardiac rehabilitation after six weeks of stable therapy and six weeks after angiography.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Advance care planning conversation, about 25 minutes, with his consent",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-09-14",
          "end": "2026-09-14"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning at the annual wellness visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "Transthoracic echocardiography after more than 90 days of therapy: ejection fraction 38% by biplane method, anterior wall and apex still thinned and akinetic, left ventricular end-diastolic diameter 58 mm (from 62), mild mitral regurgitation (from moderate), no thrombus, estimated pulmonary artery systolic pressure 30 mmHg",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "433236007",
            "display": "Transthoracic echocardiography",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "period": {
          "start": "2026-09-28",
          "end": "2026-09-28"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic repeat echocardiogram to guide the defibrillator decision.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-03-30",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose for an adult 65 or older with heart failure and no prior pneumococcal vaccine.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "High-dose influenza vaccine, this season",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "135",
            "display": "Influenza, high-dose, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination for an adult 65 or older with heart failure.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Respiratory syncytial virus vaccine, single dose",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "303",
            "display": "RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic RSV vaccination for an adult aged 60 to 74 with heart failure.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "COVID-19 vaccine, mRNA, this season",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination, chosen with him after discussion.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-09-28",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose for an adult 50 or older; second dose in two to six months.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Tetanus, diphtheria, and acellular pertussis vaccine (Tdap)",
        "status": "completed",
        "date": "2026-09-28",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-06"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Tdap; no booster recorded within ten years.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Heart attack in 1952, at about 61, one of several in his later years; details of its treatment are not recorded in the sources read",
        "historical_date": {
          "iso": "1952",
          "display": "1952",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Establishing care for six weeks of breathlessness, ankle swelling and tiredness five years after a heart attack: examination, ECG, chest X-ray, NT-proBNP and laboratory tests, a diuretic, and the plan for an echocardiogram",
        "status": "finished",
        "date": "2026-03-16",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week review: echocardiogram, heart failure cardiology consultation the same day, the diagnosis, and guideline-directed medicines",
        "status": "finished",
        "date": "2026-03-30",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Two-week review: echocardiogram, heart failure consultation and the diagnosis",
          "hpi": {
            "narrative": "Mr. Kahanamoku returns two weeks after intake and is seen the same day by Dr. Abernathy-Chen of heart failure cardiology after his echocardiogram this morning. At his wish, two members of his ʻohana joined the discussion with the cardiologist. On furosemide 40 mg he has lost 2.6 kg; his ankles swell less, and he now sleeps on one pillow. He is still breathless walking up a slope and has not been back in the water. He has had no chest pain, palpitations, fainting or lightheadedness. He took his last lisinopril dose this morning. The echocardiogram shows a weak heart muscle with an ejection fraction of 30% and an old scar at the front and tip of the heart.",
            "elements": [
              {
                "label": "Since intake",
                "value": "Weight down 2.6 kg; less ankle swelling; one pillow"
              },
              {
                "label": "Function",
                "value": "Breathless walking uphill; NYHA class III"
              },
              {
                "label": "Echocardiogram",
                "value": "Ejection fraction 30%; thinned, akinetic anterior wall and apex; moderate functional mitral regurgitation"
              },
              {
                "label": "Last lisinopril dose",
                "value": "This morning"
              }
            ]
          },
          "ros": [
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Breathless walking uphill; less ankle swelling; no chest pain, palpitations or fainting"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough; orthopnea resolved"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Passing more urine in the mornings"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No cramps"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Comfortable at rest; blood pressure 134/82, pulse 86; weight 95.0 kg, down 2.6 kg"
            },
            {
              "system": "Neck",
              "finding": "Jugular venous pressure 3 cm above the sternal angle, down from 6"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; displaced apex; soft S3; apical systolic murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Fine crackles at both bases only"
            },
            {
              "system": "Extremities",
              "finding": "Trace ankle edema, from 2+"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Heart failure with reduced ejection fraction from ischemic cardiomyopathy, NYHA class III",
              "assessment": "Breathlessness, ankle swelling, NT-proBNP 2,450 pg/mL and an ejection fraction of 30% with a thinned, akinetic anterior wall and apex establish HFrEF from an old anterior infarction. Less congested on furosemide. Potassium 3.9 mmol/L and creatinine 1.08 mg/dL (eGFR 76) two weeks after furosemide. Dr. Abernathy-Chen agrees and advises starting all four medicine classes within weeks",
              "plan": [
                "Stop lisinopril (last dose this morning); start sacubitril-valsartan 24/26 mg twice daily 36 hours after that dose",
                "Stop metoprolol tartrate; start carvedilol 3.125 mg twice daily with food this evening",
                "Start empagliflozin 10 mg daily, with sick-day rules",
                "Continue furosemide 40 mg daily and daily weights",
                "Spironolactone at the next visit if potassium and kidney function allow",
                "Metabolic panel in two weeks"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Iron deficiency without anemia",
              "assessment": "Ferritin 62 ng/mL and transferrin saturation 16% in HFrEF: intravenous iron improves symptoms and exercise capacity",
              "plan": [
                "Ferric carboxymaltose 750 mg intravenously today, and again in two weeks"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Coronary artery disease with an old anterior infarction",
              "assessment": "No angina. A new reduction in heart function needs an ischemic evaluation",
              "plan": [
                "Coronary angiography next week",
                "Continue aspirin 81 mg and atorvastatin 80 mg"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Blood pressure and heart rate (seated and standing)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "134/82 mmHg, pulse 86",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, volume status (jugular venous pressure, edema, lungs) and NYHA class",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "95.0 kg (down 2.6); jugular venous pressure 3 cm; basal crackles; trace edema; NYHA III",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium",
              "cadence": "One to two weeks after starting or changing a diuretic, ARNI, MRA or SGLT2 inhibitor; then every three to six months",
              "status": "completed_today",
              "detail": "Two weeks after furosemide: sodium 137, potassium 3.9, creatinine 1.08 mg/dL (eGFR 76), magnesium 1.9",
              "observation_ids": [
                "OBS-NA-V2",
                "OBS-K-V2",
                "OBS-CR-V2",
                "OBS-EGFR-V2",
                "OBS-GLU-V2",
                "OBS-MG-V2"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Echocardiogram",
              "cadence": "At diagnosis; repeat after three to six months of optimized therapy for device decisions, or with unexplained change",
              "status": "completed_today",
              "detail": "Ejection fraction 30%; thinned, akinetic anterior wall and apex; left ventricular end-diastolic diameter 62 mm; moderate functional mitral regurgitation",
              "observation_ids": [
                "OBS-LVEF-V2"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "ECG (rhythm and QRS width)",
              "cadence": "At diagnosis and with change or device consideration",
              "status": "up_to_date",
              "detail": "At intake: sinus rhythm, old anterior Q waves, QRS 104 ms",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "NT-proBNP",
              "cadence": "At diagnosis; selectively for prognosis (not for titration)",
              "status": "up_to_date",
              "detail": "2,450 pg/mL at intake",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Initial workup (blood count, TSH, hemoglobin A1c, lipids, liver tests)",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Hemoglobin 13.4, TSH 2.1, hemoglobin A1c 5.9%, LDL 92, ALT 28 at intake",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Iron studies (ferritin, transferrin saturation) and intravenous iron",
              "cadence": "At diagnosis; after repletion and about yearly",
              "status": "completed_today",
              "detail": "Ferritin 62 and transferrin saturation 16% at intake; ferric carboxymaltose 750 mg given today, second dose in two weeks",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Guideline-directed medical therapy: ARNI, evidence-based beta-blocker, MRA and SGLT2 inhibitor, toward target doses",
              "cadence": "Every two weeks during titration",
              "status": "completed_today",
              "detail": "Sacubitril-valsartan from 36 hours after the last lisinopril; carvedilol in place of metoprolol tartrate; empagliflozin; spironolactone next",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-HFREF-ECDP-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "KCCQ-12 heart failure health status",
              "cadence": "At diagnosis, then every three to six months",
              "status": "up_to_date",
              "detail": "38 at intake; next in two weeks",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Primary-prevention ICD evaluation (and CRT if QRS is wide)",
              "cadence": "After at least 90 days of optimized therapy, and at least 40 days after a myocardial infarction",
              "status": "due",
              "detail": "Not before 90 days of optimized therapy; QRS 104 ms, so no CRT",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-VA-ICD-2017",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "Four to twelve weeks after a statin change, then every three to twelve months",
              "status": "ordered",
              "detail": "LDL 92 mg/dL at intake; atorvastatin raised to 80 mg; panel due four to twelve weeks after the change",
              "guideline_ids": [
                "GL-CCD-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-2, then PHQ-9 if positive)",
              "cadence": "Periodically",
              "status": "up_to_date",
              "detail": "PHQ-2 1 at intake",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Cardiac rehabilitation for heart failure",
              "cadence": "When eligible: ejection fraction 35% or below, NYHA II to IV, six weeks of stable therapy and no procedure in six weeks",
              "status": "due",
              "detail": "Not yet eligible: needs six weeks of stable therapy and six weeks after angiography",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Self-care: daily weights, sodium, sick-day rules and symptoms to report",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Daily weights with a written plan; sodium plan; sick-day rules for empagliflozin",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Vaccinations (pneumococcal, influenza, COVID-19, RSV)",
              "cadence": "Pneumococcal once; others yearly or per schedule",
              "status": "completed_today",
              "detail": "PCV20 today; influenza, COVID-19 and RSV in the autumn",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-HF-2022"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Culturally safe care: ʻohana involvement as he chooses; his own healing practices",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "ʻOhana present at his wish; decisions his; lomilomi through Ke Ola Mamo offered",
              "guideline_ids": [
                "GL-KEOLAMAMO",
                "GL-NH-HF-2015"
              ]
            },
            {
              "domain": "referral",
              "measure": "Heart failure cardiology consultation",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "Seen by Dr. Abernathy-Chen today",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-HFREF-ECDP-2024",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Coronary angiography next week. Review in two weeks with a metabolic panel, the KCCQ-12 and the second iron infusion. Call for a weight gain of more than 1 kg in a day or 2 kg in a week, lightheadedness, or breathlessness at rest; call 911 for chest pain or fainting",
          "guideline_ids": [
            "GL-HF-2022",
            "GL-HFREF-ECDP-2024",
            "GL-CMID-2026",
            "GL-CCD-2023",
            "GL-KEOLAMAMO"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Two-week review after sacubitril-valsartan, carvedilol and empagliflozin: kidney function, potassium, angiography result and the next medicine",
        "status": "finished",
        "date": "2026-04-13",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Two-week review after starting sacubitril-valsartan, carvedilol and empagliflozin",
          "hpi": {
            "narrative": "Mr. Kahanamoku returns two weeks after starting carvedilol and empagliflozin and twelve days after his first dose of sacubitril-valsartan, taken as planned 36 hours after the last lisinopril. He feels better: he walks up the slope near his office without stopping, the ankle swelling has gone, and he sleeps flat. He has had no lightheadedness, cough, genital itching or burning on passing urine. His home weight is steady at 93.5 to 94 kg. Coronary angiography last week showed an old complete blockage of the main artery at the front of the heart, with collaterals, and only mild narrowing elsewhere; the cardiologist advised that opening it would not help the scarred muscle. He is ready for the second iron infusion.",
            "elements": [
              {
                "label": "Function",
                "value": "Walks uphill without stopping; NYHA class II to III"
              },
              {
                "label": "Medicine effects",
                "value": "No lightheadedness, cough or genital infection"
              },
              {
                "label": "Angiography",
                "value": "Chronic total occlusion of the proximal left anterior descending artery; mild disease elsewhere; no revascularization"
              },
              {
                "label": "KCCQ-12",
                "value": "56, from 38"
              }
            ]
          },
          "ros": [
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, ankle swelling or lightheadedness"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough; sleeps flat"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No genital itching or dysuria"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 118/72, pulse 74; weight 93.6 kg"
            },
            {
              "system": "Neck",
              "finding": "Jugular venous pressure not raised"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no S3; apical systolic murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Extremities",
              "finding": "No edema; right radial access site healed"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Heart failure with reduced ejection fraction",
              "assessment": "Improving: NYHA class II to III, euvolemic, KCCQ-12 56 from 38. Potassium 4.5 mmol/L and creatinine 1.16 mg/dL (eGFR 69), a 7% rise, expected and acceptable. Blood pressure 118/72 and pulse 74 allow the next steps",
              "plan": [
                "Start spironolactone 12.5 mg daily (potassium below 5.0 and eGFR above 30)",
                "Raise carvedilol to 6.25 mg twice daily",
                "Continue sacubitril-valsartan 24/26 mg, empagliflozin and furosemide 40 mg",
                "Metabolic panel at the review in two weeks, one to two weeks after spironolactone",
                "Sick-day rules reviewed again now that four medicines act on the kidney"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Coronary artery disease",
              "assessment": "Chronic total occlusion of the left anterior descending artery feeding a scarred, thinned wall, with mild disease elsewhere: medical therapy, not revascularization, as the cardiologist advised",
              "plan": [
                "Continue aspirin 81 mg and atorvastatin 80 mg"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Iron deficiency",
              "assessment": "First infusion two weeks ago without reaction",
              "plan": [
                "Second ferric carboxymaltose 750 mg infusion today",
                "Iron studies at about six months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Blood pressure and heart rate (seated and standing)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "118/72 mmHg, pulse 74; no orthostatic drop",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, volume status (jugular venous pressure, edema, lungs) and NYHA class",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "93.6 kg; jugular venous pressure not raised; lungs clear; no edema; NYHA II to III",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium",
              "cadence": "One to two weeks after starting or changing a diuretic, ARNI, MRA or SGLT2 inhibitor; then every three to six months",
              "status": "completed_today",
              "detail": "About two weeks after sacubitril-valsartan and empagliflozin: sodium 137, potassium 4.5, creatinine 1.16 mg/dL (eGFR 69), magnesium 2.0",
              "observation_ids": [
                "OBS-NA-V3",
                "OBS-K-V3",
                "OBS-CR-V3",
                "OBS-EGFR-V3",
                "OBS-GLU-V3",
                "OBS-MG-V3"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Guideline-directed medical therapy: ARNI, evidence-based beta-blocker, MRA and SGLT2 inhibitor, toward target doses",
              "cadence": "Every two weeks during titration",
              "status": "completed_today",
              "detail": "All four classes now started: spironolactone added and carvedilol raised today",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-HFREF-ECDP-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "SGLT2 inhibitor and ARNI: genital infection, volume depletion, hypotension and angioedema",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None; sick-day rules reviewed",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-HFREF-ECDP-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "KCCQ-12 heart failure health status",
              "cadence": "At diagnosis, then every three to six months",
              "status": "completed_today",
              "detail": "56, from 38",
              "observation_ids": [
                "OBS-KCCQ-V3"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Ischemic evaluation (coronary angiography)",
              "cadence": "At diagnosis of HFrEF with suspected coronary cause",
              "status": "up_to_date",
              "detail": "Done last week: chronic total occlusion of the proximal left anterior descending artery, mild disease elsewhere; no revascularization",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CCD-2023"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Echocardiogram",
              "cadence": "At diagnosis; repeat after three to six months of optimized therapy for device decisions, or with unexplained change",
              "status": "not_indicated",
              "detail": "Diagnosis two weeks ago; repeat after three to six months of optimized therapy",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Iron studies (ferritin, transferrin saturation) and intravenous iron",
              "cadence": "At diagnosis; after repletion and about yearly",
              "status": "completed_today",
              "detail": "Second ferric carboxymaltose 750 mg infusion today",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Primary-prevention ICD evaluation (and CRT if QRS is wide)",
              "cadence": "After at least 90 days of optimized therapy, and at least 40 days after a myocardial infarction",
              "status": "due",
              "detail": "After at least 90 days of optimized therapy",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-VA-ICD-2017",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Cardiac rehabilitation for heart failure",
              "cadence": "When eligible: ejection fraction 35% or below, NYHA II to IV, six weeks of stable therapy and no procedure in six weeks",
              "status": "due",
              "detail": "Eligible from about six weeks after angiography and the last medicine start",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Self-care: daily weights, sodium, sick-day rules and symptoms to report",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Weighs daily; less salted fish and shoyu; sick-day card given",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Culturally safe care: ʻohana involvement as he chooses; his own healing practices",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "He reviews decisions with his ʻohana at home as he chooses",
              "guideline_ids": [
                "GL-KEOLAMAMO",
                "GL-NH-HF-2015"
              ]
            }
          ],
          "follow_up": "Review in two weeks with a metabolic panel (two weeks after spironolactone), a lipid panel and the KCCQ-12. Call for lightheadedness, vomiting or diarrhea (sick-day rules), or a weight change beyond the plan",
          "guideline_ids": [
            "GL-HF-2022",
            "GL-HFREF-ECDP-2024",
            "GL-CMID-2026",
            "GL-CCD-2023"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Two-week review, five days after the sick visit: kidney function and potassium, medicine doses, lipids, and cardiac rehabilitation adapted to the ocean",
        "status": "finished",
        "date": "2026-04-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Two-week review, five days after the sick visit",
          "hpi": {
            "narrative": "Mr. Kahanamoku returns two weeks after spironolactone was added and five days after his sick visit for vomiting and diarrhea, when his potassium was 5.5 mmol/L. He followed the sick-day card: he held empagliflozin, furosemide, spironolactone and sacubitril-valsartan, took half-dose carvedilol for two days and drank oral rehydration solution. The illness settled after three days, and he restarted all his medicines two days ago. His home weight is 93 kg and steady, he has no swelling, orthopnea or lightheadedness, and he walks a mile on the flat without stopping. He is eager to be back in the ocean and asks how to do it safely.",
            "elements": [
              {
                "label": "Since the sick visit",
                "value": "Medicines held for three days, restarted two days ago; no further vomiting or diarrhea"
              },
              {
                "label": "Home weight",
                "value": "93 kg, steady"
              },
              {
                "label": "Function",
                "value": "Walks a mile on the flat; NYHA class II"
              },
              {
                "label": "KCCQ-12",
                "value": "66, from 56"
              }
            ]
          },
          "ros": [
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No vomiting or diarrhea since three days ago; eating normally"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, ankle swelling or lightheadedness"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No breathlessness at rest; sleeps flat"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No muscle aches on atorvastatin 80 mg"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 112/70, pulse 68; weight 93.0 kg"
            },
            {
              "system": "Orthostatic vital signs",
              "finding": "Standing at three minutes 108/68 mmHg without symptoms"
            },
            {
              "system": "Neck",
              "finding": "Jugular venous pressure not raised"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no S3; apical systolic murmur"
            },
            {
              "system": "Extremities",
              "finding": "No edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Heart failure with reduced ejection fraction",
              "assessment": "Euvolemic at a dry weight of about 93 kg, NYHA class II, KCCQ-12 66. Potassium 4.8 mmol/L and creatinine 1.20 mg/dL (eGFR 67) two days after restarting, back near baseline, so the sick-day rules worked. Pulse 68 and blood pressure 112/70 allow a beta-blocker increase; one change at a time after the illness",
              "plan": [
                "Raise carvedilol to 12.5 mg twice daily",
                "Reduce furosemide to 20 mg daily now that he is dry",
                "Raise sacubitril-valsartan to 49/51 mg twice daily in two weeks by the heart failure nurse, with a metabolic panel one week after that change",
                "Continue empagliflozin and spironolactone 12.5 mg"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Coronary artery disease",
              "assessment": "LDL 62 mg/dL six weeks after atorvastatin was raised to 80 mg, at goal; ALT 31 U/L",
              "plan": [
                "Continue atorvastatin 80 mg and aspirin 81 mg"
              ]
            },
            {
              "display": "Exercise and the ocean",
              "assessment": "He will be eligible for cardiac rehabilitation for heart failure in about four weeks, six weeks after his angiography and his last new medicine",
              "plan": [
                "Cardiac rehabilitation, 36 sessions, from late May, with pool swimming once the team agrees",
                "Until then, walking only; no swimming or surfing yet",
                "Ocean plan after rehabilitation: calm water inside the reef, with a companion and near a lifeguard; no breath-hold diving; no big surf until cleared; water through the morning; out of the water at once for chest pain, lightheadedness or unusual breathlessness"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Blood pressure and heart rate (seated and standing)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "112/70 mmHg, pulse 68; standing 108/68 without symptoms",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, volume status (jugular venous pressure, edema, lungs) and NYHA class",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "93.0 kg; jugular venous pressure not raised; no edema; NYHA II",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium",
              "cadence": "One to two weeks after starting or changing a diuretic, ARNI, MRA or SGLT2 inhibitor; then every three to six months",
              "status": "completed_today",
              "detail": "Two weeks after spironolactone and two days after restarting held medicines: sodium 137, potassium 4.8, creatinine 1.20 mg/dL (eGFR 67), magnesium 2.0. The one-to-two-week check after spironolactone was also covered by the sick-visit panel at nine days (potassium 5.5 during volume depletion)",
              "observation_ids": [
                "OBS-NA-V4",
                "OBS-K-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4",
                "OBS-GLU-V4",
                "OBS-MG-V4"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Guideline-directed medical therapy: ARNI, evidence-based beta-blocker, MRA and SGLT2 inhibitor, toward target doses",
              "cadence": "Every two weeks during titration",
              "status": "completed_today",
              "detail": "Carvedilol raised today; sacubitril-valsartan increase planned in two weeks by the nurse, with a panel a week later",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-HFREF-ECDP-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "MRA and ARNI: potassium and kidney function during illness",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Sick-day rules used correctly; potassium back to 4.8",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-HFREF-ECDP-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "Four to twelve weeks after a statin change, then every three to twelve months",
              "status": "completed_today",
              "detail": "Six weeks after atorvastatin 80 mg: LDL 62 mg/dL, total cholesterol 130, HDL 45, triglycerides 115; ALT 31 U/L",
              "observation_ids": [
                "OBS-CHOL-V4",
                "OBS-LDL-V4",
                "OBS-HDL-V4",
                "OBS-TG-V4",
                "OBS-ALT-V4"
              ],
              "guideline_ids": [
                "GL-CCD-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "KCCQ-12 heart failure health status",
              "cadence": "At diagnosis, then every three to six months",
              "status": "completed_today",
              "detail": "66, from 56",
              "observation_ids": [
                "OBS-KCCQ-V4"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Echocardiogram",
              "cadence": "At diagnosis; repeat after three to six months of optimized therapy for device decisions, or with unexplained change",
              "status": "not_indicated",
              "detail": "Repeat after three to six months of optimized therapy",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Primary-prevention ICD evaluation (and CRT if QRS is wide)",
              "cadence": "After at least 90 days of optimized therapy, and at least 40 days after a myocardial infarction",
              "status": "due",
              "detail": "After at least 90 days of optimized therapy",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-VA-ICD-2017",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Cardiac rehabilitation for heart failure",
              "cadence": "When eligible: ejection fraction 35% or below, NYHA II to IV, six weeks of stable therapy and no procedure in six weeks",
              "status": "ordered",
              "detail": "Program booked from late May, when he becomes eligible",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Self-care: daily weights, sodium, sick-day rules and symptoms to report",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Sick-day card used well; daily weights; dry weight 93 kg",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Culturally safe care: ʻohana involvement as he chooses; his own healing practices",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No Native Hawaiian practices raised today; offer remains open",
              "guideline_ids": [
                "GL-KEOLAMAMO",
                "GL-NH-HF-2015"
              ]
            }
          ],
          "follow_up": "Heart failure nurse call in two weeks to raise sacubitril-valsartan, with a metabolic panel one week later. Cardiac rehabilitation from late May. Annual wellness visit in September; heart failure review in about five months with a repeat echocardiogram",
          "guideline_ids": [
            "GL-HF-2022",
            "GL-HFREF-ECDP-2024",
            "GL-CMID-2026",
            "GL-CCD-2023"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Six-month review: repeat echocardiogram after more than 90 days of therapy, the defibrillator decision, iron, the delayed titration step, and plans for the year",
        "status": "finished",
        "date": "2026-09-28",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Six-month review: repeat echocardiogram and the defibrillator decision",
          "hpi": {
            "narrative": "Mr. Kahanamoku returns two weeks after his annual wellness visit; at his wish, members of his ʻohana joined him for the defibrillator discussion. He completed all 36 sessions of cardiac rehabilitation in the summer, swam in the pool there for the last month, and now swims three mornings a week in calm water inside the reef with a friend; he has not surfed big waves. He has had no swelling, orthopnea, palpitations, lightheadedness or fainting. The planned increase of sacubitril-valsartan two weeks after his last review did not happen: the nurse called, but he put off the laboratory visit twice because of work, the call was not repeated, and he stayed on the starting dose. He takes every dose of his medicines. Today's echocardiogram shows the ejection fraction has risen from 30% to 38%.",
            "elements": [
              {
                "label": "Rehabilitation",
                "value": "All 36 sessions completed"
              },
              {
                "label": "Activity",
                "value": "Swims three mornings a week in calm water with a companion"
              },
              {
                "label": "Missed step",
                "value": "Sacubitril-valsartan increase and its laboratory check did not happen"
              },
              {
                "label": "Echocardiogram",
                "value": "Ejection fraction 38%, from 30%"
              },
              {
                "label": "KCCQ-12",
                "value": "80, from 38 at intake"
              }
            ]
          },
          "ros": [
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, fainting or ankle swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "Breathless only swimming hard against a current"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No lightheadedness"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 106/66, pulse 64; weight 92.8 kg"
            },
            {
              "system": "Orthostatic vital signs",
              "finding": "Standing at three minutes 104/64 mmHg without symptoms"
            },
            {
              "system": "Neck",
              "finding": "Jugular venous pressure not raised"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; soft apical systolic murmur; no S3"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Extremities",
              "finding": "No edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Heart failure with reduced ejection fraction",
              "assessment": "Much better: NYHA class I to II, KCCQ-12 80, NT-proBNP 620 pg/mL from 2,450, and an ejection fraction of 38% from 30% after more than five months on all four classes. Potassium 4.6 mmol/L and creatinine 1.14 mg/dL (eGFR 70). Sacubitril-valsartan is still at the starting dose because a titration step was missed",
              "plan": [
                "Raise sacubitril-valsartan to 49/51 mg twice daily today; standing blood pressure 104/64 without symptoms allows it",
                "Metabolic panel in one to two weeks, drawn at the clinic, with nurse calls for further steps",
                "Continue carvedilol 12.5 mg twice daily, empagliflozin, spironolactone 12.5 mg and furosemide 20 mg"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Defibrillator decision",
              "assessment": "The ejection fraction is 38%, above the 35% threshold, after more than 90 days of therapy and years after the infarction, so a primary-prevention ICD is not indicated. QRS 104 ms, so no CRT. He and his ʻohana were told what would change this",
              "plan": [
                "Repeat echocardiogram if symptoms worsen or after further titration if his course changes",
                "Call 911 for fainting or a racing heartbeat"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Iron deficiency",
              "assessment": "Repleted: ferritin 248 ng/mL, transferrin saturation 27%, hemoglobin 14.1 g/dL",
              "plan": [
                "Iron studies yearly"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Blood pressure and heart rate (seated and standing)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "106/66 mmHg, pulse 64; standing 104/64 without symptoms",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Weight, volume status (jugular venous pressure, edema, lungs) and NYHA class",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "92.8 kg; jugular venous pressure not raised; no edema; NYHA I to II",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium",
              "cadence": "One to two weeks after a dose change",
              "status": "deferred",
              "detail": "The panel due one week after the planned sacubitril-valsartan increase was never drawn, because the increase itself did not happen: he put off the laboratory visit twice for work and the nurse's call was not repeated. No laboratory harm resulted (potassium 4.6, creatinine 1.14 today), but the ARNI stayed at the starting dose for about five months, which may have limited his recovery. Corrective action: laboratory tests drawn at the clinic on the day of each change or by the nurse at home, and nurse calls that continue until each step is done",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-HFREF-ECDP-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium",
              "cadence": "Every three to six months when stable",
              "status": "completed_today",
              "detail": "Sodium 138, potassium 4.6, creatinine 1.14 mg/dL (eGFR 70), magnesium 2.0",
              "observation_ids": [
                "OBS-NA-V5",
                "OBS-K-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5",
                "OBS-GLU-V5",
                "OBS-MG-V5"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Guideline-directed medical therapy: ARNI, evidence-based beta-blocker, MRA and SGLT2 inhibitor, toward target doses",
              "cadence": "Every two weeks during titration",
              "status": "completed_today",
              "detail": "Sacubitril-valsartan raised to 49/51 mg today; panel in one to two weeks",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-HFREF-ECDP-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Echocardiogram",
              "cadence": "At diagnosis; repeat after three to six months of optimized therapy for device decisions, or with unexplained change",
              "status": "completed_today",
              "detail": "After more than 90 days of therapy: ejection fraction 38% (from 30%), end-diastolic diameter 58 mm, mild mitral regurgitation",
              "observation_ids": [
                "OBS-LVEF-V5"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Primary-prevention ICD evaluation (and CRT if QRS is wide)",
              "cadence": "After at least 90 days of optimized therapy, and at least 40 days after a myocardial infarction",
              "status": "not_indicated",
              "detail": "Ejection fraction 38%, above 35%; QRS 104 ms; no ICD or CRT now",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-VA-ICD-2017",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "NT-proBNP",
              "cadence": "At diagnosis; selectively for prognosis (not for titration)",
              "status": "completed_today",
              "detail": "620 pg/mL, from 2,450, for prognosis",
              "observation_ids": [
                "OBS-NTPROBNP-V5"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Iron studies (ferritin, transferrin saturation) and intravenous iron",
              "cadence": "At diagnosis; after repletion and about yearly",
              "status": "completed_today",
              "detail": "Ferritin 248 ng/mL, transferrin saturation 27%, hemoglobin 14.1 g/dL",
              "observation_ids": [
                "OBS-FER-V5",
                "OBS-TSAT-V5",
                "OBS-HGB-V5"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "KCCQ-12 heart failure health status",
              "cadence": "At diagnosis, then every three to six months",
              "status": "completed_today",
              "detail": "80",
              "observation_ids": [
                "OBS-KCCQ-V5"
              ],
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "Every three to twelve months when stable",
              "status": "up_to_date",
              "detail": "LDL 62 mg/dL in the spring",
              "guideline_ids": [
                "GL-CCD-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-2, then PHQ-9 if positive)",
              "cadence": "Periodically",
              "status": "up_to_date",
              "detail": "PHQ-2 0 at the wellness visit",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Cardiac rehabilitation for heart failure",
              "cadence": "When eligible: ejection fraction 35% or below, NYHA II to IV, six weeks of stable therapy and no procedure in six weeks",
              "status": "completed_today",
              "detail": "All 36 sessions completed in the summer; swimming in calm water with a companion",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Vaccinations (pneumococcal, influenza, COVID-19, RSV)",
              "cadence": "Yearly or per schedule",
              "status": "completed_today",
              "detail": "Influenza, RSV and COVID-19 at the wellness visit; PCV20 in the spring; zoster dose 1 and Tdap today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026",
                "GL-HF-2022"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Self-care: daily weights, sodium, sick-day rules and symptoms to report",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Daily weights; ocean plan followed; sick-day card kept in his wallet",
              "guideline_ids": [
                "GL-HF-2022",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Culturally safe care: ʻohana involvement as he chooses; his own healing practices",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "ʻOhana included in the defibrillator discussion, as he asked at the wellness visit",
              "guideline_ids": [
                "GL-KEOLAMAMO",
                "GL-NH-HF-2015"
              ]
            }
          ],
          "follow_up": "Zoster dose 1 and Tdap given today; second zoster dose in two to six months. Metabolic panel at the clinic in one to two weeks, with the nurse's call. Review in three months. Cardiology review in six months. Call 911 for chest pain, fainting or a racing heartbeat",
          "guideline_ids": [
            "GL-HF-2022",
            "GL-HFREF-ECDP-2024",
            "GL-VA-ICD-2017",
            "GL-CMID-2026",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for vomiting and diarrhea on heart failure medicines",
        "status": "finished",
        "date": "2026-04-22",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Vomiting and diarrhea for two days",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. Kahanamoku, a 66-year-old man with heart failure with reduced ejection fraction, called the heart failure nurse and was seen the same day. Two days ago he began vomiting and then had watery diarrhea, five or six times a day, without blood. Several people at his workplace have had the same illness this week. He has kept down only small sips of water since yesterday and has not taken his morning medicines today, but he took all of them yesterday, including spironolactone, which was started nine days ago. His home weight is 2.2 kg below his dry weight. He feels lightheaded on standing. He has no chest pain, palpitations, breathlessness, ankle swelling or fainting, and no fever above 38 degrees.",
            "elements": [
              {
                "label": "Onset",
                "value": "Two days ago"
              },
              {
                "label": "Character",
                "value": "Vomiting, then watery diarrhea five or six times a day, without blood"
              },
              {
                "label": "Context",
                "value": "Similar illness among co-workers; heart failure medicines, spironolactone started nine days ago"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Lightheaded on standing; weight 2.2 kg below dry weight. Denies chest pain, breathlessness and fainting"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired and thirsty; low-grade temperature; weight down 2.2 kg"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Vomiting and watery diarrhea; mild cramping; no blood or black stools"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or ankle swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No breathlessness or orthopnea"
            },
            {
              "system": "Genitourinary",
              "status": "positive",
              "finding": "Passing little urine since yesterday"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but alert; seated blood pressure 102/62, pulse 96, temperature 37.6"
            },
            {
              "system": "Orthostatic vital signs",
              "finding": "Lying 108/66 mmHg, pulse 88; standing at three minutes 90/58 mmHg, pulse 108, with lightheadedness"
            },
            {
              "system": "Head and neck",
              "finding": "Dry mucous membranes; jugular venous pressure not seen at 45 degrees"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no gallop"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, mildly tender throughout, no guarding; active bowel sounds"
            },
            {
              "system": "Extremities",
              "finding": "No edema"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-005",
              "display": "Viral gastroenteritis with volume depletion and a raised potassium",
              "assessment": "A self-limited viral illness, as among his co-workers, with volume depletion: orthostatic fall in blood pressure, weight 2.2 kg below dry weight, sodium 133 mmol/L, creatinine 1.52 mg/dL from 1.16 and potassium 5.5 mmol/L, from reduced kidney blood flow on four medicines that act on the kidney. The ECG shows no changes of hyperkalemia. He can drink small amounts and does not need hospital care today",
              "plan": [
                "Sick-day rules: hold empagliflozin, furosemide, spironolactone and sacubitril-valsartan until he is eating and drinking normally for a day",
                "Halve carvedilol for two days while he is lightheaded, then return to the full dose",
                "Oral rehydration solution in small amounts often, about 2 liters today; bland food as tolerated",
                "Restart the held medicines one day after the illness settles, and weigh daily",
                "Recheck potassium and creatinine at the review in five days, or sooner if he cannot keep fluids down"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Heart failure with reduced ejection fraction",
              "assessment": "Dry, not congested",
              "plan": [
                "Call if his weight rises more than 1 kg in a day or 2 kg in a week after restarting"
              ]
            }
          ],
          "follow_up": "Heart failure nurse telephone call tomorrow. Review in five days with a metabolic panel. Go to the emergency department for fainting, vomiting that prevents any fluid intake, palpitations, weakness or chest pain",
          "guideline_ids": [
            "GL-HF-2022",
            "GL-HFREF-ECDP-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the illness is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Subsequent annual wellness visit",
        "status": "finished",
        "date": "2026-09-14",
        "visit_type": "annual_wellness_subsequent",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "281038008",
          "display": "Geriatric annual health check",
          "validation_status": "validated",
          "validated_on": "2026-11-06"
        },
        "documentation": {
          "chief_complaint": "Subsequent annual wellness visit; no new complaints",
          "billing_note": "HCPCS G0439 (subsequent annual wellness visit) with CPT 99497 (advance care planning), both on the same day",
          "hpi": {
            "narrative": "Mr. Kahanamoku returns for his subsequent annual wellness visit; his first was with his previous primary care physician last year. He completed the health risk assessment with the medical assistant. He finished cardiac rehabilitation in the summer and now swims three mornings a week in calm water inside the reef with a friend. He is working full days as sheriff. He has had no swelling, orthopnea or lightheadedness since the spring, and no further illness. He asks what screening he needs.",
            "elements": [
              {
                "label": "Visit",
                "value": "Subsequent annual wellness visit"
              },
              {
                "label": "Safety events",
                "value": "No falls or hospital stays in the past year; one sick visit in the spring"
              },
              {
                "label": "Medicines",
                "value": "Seven medicines, taken from a weekly pill box; no supplements or plant medicines"
              },
              {
                "label": "Active conditions",
                "value": "Heart failure with reduced ejection fraction and coronary disease, stable"
              },
              {
                "label": "Functional status",
                "value": "Independent in all activities and instrumental activities of daily living"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, and much better than in the spring"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy at work; close to his ʻohana and friends; no stress he cannot manage"
            },
            {
              "domain": "Behavioral",
              "finding": "Never smoker; no alcohol; swims three mornings a week and walks daily; less salt; sleeps about seven hours on one pillow"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent in bathing, dressing, eating, toileting and transfers"
            },
            {
              "domain": "Instrumental activities of daily living",
              "finding": "Manages his own medicines, money, driving and work"
            },
            {
              "domain": "Home safety",
              "finding": "Smoke detector working; no loose rugs; grab bar in the shower"
            },
            {
              "domain": "Hearing and vision",
              "finding": "Hears well in quiet rooms; reading glasses; eye examination two years ago"
            },
            {
              "domain": "Sun exposure",
              "finding": "A lifetime in the sun and the water; uses a hat now"
            },
            {
              "domain": "Memory",
              "finding": "No concerns"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight steady at his dry weight; no fever or fatigue"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hearing loss or ear pain"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations, orthopnea or ankle swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "Breathless only when swimming hard against a current"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Regular bowel habit; no bleeding"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms or genital itching"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "Stiff shoulders in the morning; no falls"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No new or changing skin lesions"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, weakness, numbness or speech change"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 0"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; blood pressure 108/68, pulse 64"
            },
            {
              "system": "Eyes",
              "finding": "Pupils equal and reactive; near vision 20/30 with reading glasses"
            },
            {
              "system": "Ears",
              "finding": "Whispered-voice test passed on both sides"
            },
            {
              "system": "Neck",
              "finding": "Jugular venous pressure not raised; no carotid bruits"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; soft apical systolic murmur of mitral regurgitation; no gallop; no edema"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Timed Up and Go 8 seconds with a steady gait"
            },
            {
              "system": "Neurological",
              "finding": "Oriented; Mini-Cog 5 of 5"
            },
            {
              "system": "Skin",
              "finding": "Sun-damaged skin of the face and forearms; no suspicious lesions"
            },
            {
              "system": "Psychiatric",
              "finding": "Calm and engaged"
            }
          ],
          "assessment_plan": [
            {
              "display": "Subsequent annual wellness visit completed",
              "assessment": "Health risk assessment reviewed, personalized prevention plan updated and a written copy given. Depression, alcohol, cognitive and fall-risk screens are negative",
              "plan": [
                "Next annual wellness visit in one year"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Heart failure with reduced ejection fraction",
              "assessment": "NYHA class I to II and euvolemic",
              "plan": [
                "Six-month review in two weeks with a repeat echocardiogram and laboratory tests"
              ]
            },
            {
              "display": "Prediabetes (hemoglobin A1c 5.9% in the spring)",
              "assessment": "Exercise and less refined starch help; empagliflozin, taken for his heart, also lowers glucose",
              "plan": [
                "Hemoglobin A1c at one year"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Influenza vaccine",
              "status": "completed_today",
              "detail": "High-dose vaccine given today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "RSV vaccine",
              "status": "completed_today",
              "detail": "Single dose today; heart failure raises his risk",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "completed_today",
              "detail": "This season's vaccine given today after discussion",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 given at the two-week visit in the spring",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "due",
              "detail": "Never given; first dose at the six-month review",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus booster",
              "status": "due",
              "detail": "No record within ten years; Tdap at the six-month review, also advised for reef and coral cuts",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "Age 45 to 75; no screening on record; a stool immunochemical (FIT) kit given today",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Prostate cancer screening",
              "status": "declined",
              "detail": "Age 55 to 69: a PSA test is an individual decision; benefits and harms discussed and he chose not to be tested now",
              "guideline_ids": [
                "GL-USPSTF-PROSTATE-2018"
              ]
            },
            {
              "service": "Abdominal aortic aneurysm screening",
              "status": "not_indicated",
              "detail": "Recommended for men 65 to 75 who have ever smoked; he never smoked, and after discussion chose not to have the selective test",
              "guideline_ids": [
                "GL-USPSTF-AAA-2019"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Never smoker"
            },
            {
              "service": "Hepatitis C screening",
              "status": "ordered",
              "detail": "One-time screening for adults 18 to 79; never tested",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0"
            },
            {
              "service": "Alcohol misuse screening",
              "status": "completed_today",
              "detail": "AUDIT-C score 0"
            },
            {
              "service": "Cognitive assessment",
              "status": "completed_today",
              "detail": "Mini-Cog 5 of 5"
            },
            {
              "service": "Falls prevention",
              "status": "completed_today",
              "detail": "Timed Up and Go 8 seconds; no falls",
              "guideline_ids": [
                "GL-USPSTF-FALLS-2024"
              ]
            },
            {
              "service": "Skin check",
              "status": "completed_today",
              "detail": "Sun-damaged skin without suspicious lesions; hat, shirt and sunscreen for time on the water"
            },
            {
              "service": "Blood pressure, cholesterol and diabetes screening",
              "status": "up_to_date",
              "detail": "Blood pressure at every visit; LDL 62 mg/dL in the spring; hemoglobin A1c 5.9% in the spring"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 25 minutes, with his consent and, at his wish, with members of his ʻohana present. He named a member of his ʻohana as his health care agent, and the Hawaiʻi advance health care directive was completed and copied into the chart. He wants full treatment, including resuscitation, for illness he can recover from. If his heart failure advanced so that he could no longer leave his bed, he would want comfort and time at home over repeated hospital stays. If a defibrillator is ever offered, he wants to talk about it with his ʻohana first. He asked that his own Hawaiian practices at the end of life be respected as he and his ʻohana choose; they were not described and nothing further was asked.",
          "follow_up": "FIT kit to return by mail; hepatitis C test drawn today. Six-month review in two weeks with a repeat echocardiogram, metabolic panel, iron studies and NT-proBNP. Next annual wellness visit in one year",
          "guideline_ids": [
            "GL-AWV-CMS",
            "GL-PREV-2026",
            "GL-USPSTF-CRC-2021",
            "GL-USPSTF-PROSTATE-2018",
            "GL-USPSTF-AAA-2019",
            "GL-USPSTF-FALLS-2024",
            "GL-USPSTF-HCV-2020",
            "GL-CDC-IMZ-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Medicare annual wellness visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-03-16",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 97.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 142,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 86,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 92,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 20,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 94,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings after five minutes' rest. No measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-03-30",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 95.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 134,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 86,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 18,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 96,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings after five minutes' rest. No measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-04-13",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 93.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings after five minutes' rest. No measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-04-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 93.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 112,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings after five minutes' rest. No measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-09-28",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 92.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 106,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 66,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 64,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.5,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings after five minutes' rest. No measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-04-22",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 91.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 102,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 62,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 96,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the sick visit; lying and standing readings are in the note.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-09-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 185,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 92.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.1,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 108,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 68,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 64,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the annual wellness visit, average of two readings.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Sheriff of Honolulu, elected many times; a former Olympic champion swimmer and a surfer who helped carry surfing to the world; until six weeks ago he swam and surfed at Waikīkī most mornings",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0006",
            "CLM-0014"
          ],
          "synthetic_reason": "Synthetic modern occupation and activity anchored to his documented career.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Native Hawaiian, born and raised in Honolulu; asked to be called Mr. Kahanamoku in the clinic; speaks English with Hawaiian words where he prefers them",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0001"
          ],
          "synthetic_reason": "Synthetic modern social history anchored to his documented birth in Honolulu.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "ʻOhana: he wants members of his ʻohana present for big decisions when he chooses, and he makes the decisions; lives at home in Honolulu",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0001"
          ],
          "synthetic_reason": "Synthetic household description; no relative is named or given a role in his care.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Tobacco: never. Alcohol: never. No drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic substance history, consistent with the documented record that he never drank or smoked.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Diet: fish, poi, rice, fruit and greens at home; salted and dried fish and shoyu at times; many meals at public events where food is salty",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diet history, in his own words; no claim about his real diet.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Income: a county salary as sheriff; modest means; county health plan with Medicare",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0013",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic financial history anchored to his documented lack of great personal wealth.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-007",
        "display": "Traditional healing: he has his own Native Hawaiian practices and will decide whether and how they are part of his care; lomilomi through a Native Hawaiian Health Care System was offered alongside clinic care, and nothing further was asked",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic statement in the modern episode; no practice or ceremony is described.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-008",
        "display": "Strengths: a lifetime of discipline in training, calm under pressure, deep knowledge of the ocean, and a wide circle in the community",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic strengths anchored to his documented athletic career.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all daily activities; breathless walking up a gentle slope or paddling out through small surf; has stopped his morning swim after a few minutes; sleeps on two pillows; NYHA class III",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status for the presenting breathlessness.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, calm and courteous; frustrated at being kept from the water; mood steady; PHQ-2 score 1",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Six weeks of breathlessness, ankle swelling and tiredness in a 66-year-old Native Hawaiian man five years after a heart attack, with NT-proBNP 2,450 pg/mL, old anterior Q waves and an enlarged heart on chest X-ray. Please confirm the diagnosis and cause, advise on guideline-directed medical therapy and its order, the ischemic evaluation and device decisions, and how he can return to swimming and surfing safely",
        "urgency": "Soon; on the day of his two-week visit, after the echocardiogram that morning",
        "pertinent_history": "Sheriff of Honolulu and a lifelong swimmer and surfer; never smoked or drank. Heart attack five years ago treated with medicines; on aspirin 81 mg, atorvastatin 40 mg, metoprolol tartrate 25 mg twice daily and lisinopril 10 mg since then. Six weeks of breathlessness on slopes and while paddling, two-pillow orthopnea, evening ankle swelling and tiredness; NYHA class III. Today blood pressure 142/86, pulse 92, oxygen saturation 94%; jugular venous pressure 6 cm, basal crackles, 2+ ankle edema, soft S3. ECG: sinus rhythm, Q waves in V1 to V4, QRS 104 ms. Chest X-ray: enlarged heart, venous diversion, small effusions. NT-proBNP 2,450 pg/mL; sodium 138, potassium 4.2 mmol/L, creatinine 1.02 mg/dL (eGFR 81); hemoglobin 13.4 g/dL; ferritin 62 ng/mL, transferrin saturation 16%; TSH 2.1; hemoglobin A1c 5.9%; LDL 92 mg/dL. Started furosemide 40 mg daily and raised atorvastatin to 80 mg today. He wants his ʻohana involved in decisions as he chooses, and he makes the decisions",
        "questions": [
          "Does he have heart failure with reduced ejection fraction, and is the cause ischemic?",
          "Does he need an ischemic evaluation, and could revascularization help?",
          "Which guideline-directed medicines should he start, in what order, and how should lisinopril and metoprolol tartrate be changed?",
          "Should his iron deficiency be treated, and how?",
          "When should a defibrillator or resynchronization device be considered?",
          "How and when can he safely return to swimming and surfing?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Kahanamoku, a 66-year-old Native Hawaiian man who is sheriff of Honolulu and a lifelong swimmer and surfer, is seen at the request of Dr. Lindgren-Morrison on the day of his echocardiogram. At his wish, two members of his ʻohana joined the discussion; he made the decisions. He had a heart attack five years ago, treated with medicines. For about eight weeks he has been breathless on slopes and while paddling, with orthopnea and ankle swelling that have eased on two weeks of furosemide. He has no chest pain, palpitations or fainting. He has never smoked or drunk alcohol",
        "data_reviewed": "Dr. Lindgren-Morrison's intake note. ECG: sinus rhythm, Q waves in V1 to V4, QRS 104 ms, no left bundle branch block. Chest X-ray: enlarged heart, upper-lobe venous diversion and small effusions. NT-proBNP 2,450 pg/mL. Echocardiogram this morning: ejection fraction 30% by biplane method, thinned and akinetic anterior wall and apex, left ventricular end-diastolic diameter 62 mm, no thrombus, moderate functional mitral regurgitation, normal right ventricle, estimated pulmonary artery systolic pressure 42 mmHg. Metabolic panel today: potassium 3.9 mmol/L, creatinine 1.08 mg/dL (eGFR 76), magnesium 1.9 mg/dL. Ferritin 62 ng/mL, transferrin saturation 16%, hemoglobin 13.4 g/dL; TSH 2.1; LDL 92 mg/dL on atorvastatin 40 mg",
        "exam": [
          {
            "system": "General",
            "finding": "Comfortable at rest; blood pressure 134/82, pulse 86; weight 95.0 kg"
          },
          {
            "system": "Neck",
            "finding": "Jugular venous pressure 3 cm above the sternal angle"
          },
          {
            "system": "Cardiovascular",
            "finding": "Regular rhythm; displaced apex; soft S3; apical systolic murmur of functional mitral regurgitation"
          },
          {
            "system": "Respiratory",
            "finding": "Fine crackles at both bases only"
          },
          {
            "system": "Extremities",
            "finding": "Trace ankle edema"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-003",
            "display": "Diagnosis and cause",
            "assessment": "Heart failure with reduced ejection fraction, stage C, NYHA class III, from ischemic cardiomyopathy: an ejection fraction of 30% with a thinned, akinetic anterior wall and apex in the territory of the old anterior infarction, and Q waves to match. The mitral regurgitation is functional, from the dilated ventricle. TSH and blood count exclude thyroid disease and anemia as contributors; he does not drink alcohol"
          },
          {
            "problem_id": "PRB-002",
            "display": "Ischemic evaluation",
            "assessment": "Invasive coronary angiography is reasonable in new HFrEF with a likely coronary cause, to define the anatomy and look for disease that revascularization could help, especially in vessels other than the infarct artery. A thinned, akinetic wall of 5 mm or less is unlikely to recover even if its artery is opened"
          },
          {
            "problem_id": "PRB-003",
            "display": "Guideline-directed medical therapy",
            "assessment": "Start all four classes within weeks rather than months. Stop lisinopril and begin sacubitril-valsartan 24/26 mg twice daily at least 36 hours after the last lisinopril dose, to avoid angioedema. Replace metoprolol tartrate, which is not one of the beta-blockers proven in heart failure, with carvedilol 3.125 mg twice daily. Start empagliflozin 10 mg now. Add spironolactone 12.5 mg at the next visit if potassium is below 5.0 mmol/L and eGFR above 30. Then raise one medicine every two weeks toward target doses (sacubitril-valsartan 97/103 mg and carvedilol 25 mg twice daily) as blood pressure, heart rate, potassium and kidney function allow, with a metabolic panel one to two weeks after each change. Keep furosemide at the lowest dose that keeps him dry. Teach sick-day rules"
          },
          {
            "problem_id": "PRB-004",
            "display": "Iron deficiency",
            "assessment": "Ferritin below 100 ng/mL is iron deficiency in heart failure even without anemia. Intravenous iron improves symptoms, exercise capacity and quality of life; oral iron does not. Give ferric carboxymaltose 750 mg today and again in two weeks, and check iron studies at about six months"
          },
          {
            "display": "Defibrillator and resynchronization",
            "assessment": "Not now. Repeat the echocardiogram after at least 90 days of optimized therapy; a primary-prevention ICD is indicated if the ejection fraction is still 35% or below with NYHA class II to III and a good expected survival. His QRS of 104 ms does not meet criteria for resynchronization"
          },
          {
            "display": "Exercise and the ocean",
            "assessment": "Exercise training is safe and helps in stable HFrEF. Cardiac rehabilitation for heart failure is covered once he has had six weeks of stable therapy and no procedure in the previous six weeks. Until then, walking. After rehabilitation, swimming is reasonable in calm water with a companion; breath-hold diving and big surf should wait until he is clearly stable, because a sudden loss of consciousness in the water is the main danger. Drink water through the morning on the diuretic and empagliflozin"
          }
        ],
        "recommendations": [
          "Stop lisinopril; start sacubitril-valsartan 24/26 mg twice daily 36 hours after the last dose",
          "Change metoprolol tartrate to carvedilol 3.125 mg twice daily",
          "Start empagliflozin 10 mg daily with sick-day rules",
          "Add spironolactone 12.5 mg daily at the next visit if potassium is below 5.0 mmol/L and eGFR above 30",
          "Raise one medicine every two weeks toward target doses, with a metabolic panel one to two weeks after each change",
          "Continue furosemide at the lowest dose that keeps him euvolemic",
          "Ferric carboxymaltose 750 mg intravenously today and in two weeks; iron studies at about six months",
          "Invasive coronary angiography within two weeks",
          "Repeat echocardiogram after at least 90 days of optimized therapy to decide on a primary-prevention ICD",
          "Cardiac rehabilitation for heart failure when eligible, then a graded return to the ocean",
          "Pneumococcal vaccine now; influenza, COVID-19 and RSV vaccines in the autumn"
        ],
        "communication": "Discussed with Dr. Lindgren-Morrison, who saw him the same day. The diagnosis, each medicine and the angiography were explained plainly to Mr. Kahanamoku and, at his wish, to members of his ʻohana; he agreed to the plan",
        "follow_up": "Dr. Lindgren-Morrison continues his care, with the heart failure nurse for titration. Cardiology will review the angiogram and the repeat echocardiogram, and will see him sooner for worsening symptoms, fainting or palpitations"
      },
      "guideline_ids": [
        "GL-HF-2022",
        "GL-HFREF-ECDP-2024",
        "GL-VA-ICD-2017",
        "GL-CCD-2023",
        "GL-CMID-2026"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He wants to get back in the ocean, to swim and surf again",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He wants to keep working as sheriff",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He wants his ʻohana involved as he chooses and his own ways of healing respected",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Euvolemia: no ankle swelling or orthopnea, with a steady dry weight",
        "status": "completed",
        "target_date": "2026-04-27",
        "outcome": "Dry weight about 93 kg; no edema or orthopnea; furosemide reduced to 20 mg",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic congestion goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "All four guideline-directed medicines at the highest doses he tolerates within three months",
        "status": "active",
        "target_date": "2026-09-28",
        "outcome": "All four classes started within two weeks of diagnosis; carvedilol 12.5 mg twice daily, empagliflozin and spironolactone at their doses; sacubitril-valsartan stayed at the starting dose for five months after a missed titration step and was raised at six months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GDMT goal under the 2024 ACC decision pathway; not met on time.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "KCCQ-12 at least 20 points higher and NYHA class I to II within six months",
        "status": "completed",
        "target_date": "2026-09-28",
        "outcome": "KCCQ-12 38 to 80; NYHA class I to II",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic health-status goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Back in the ocean safely, swimming in calm water with a companion",
        "status": "completed",
        "target_date": "2026-09-28",
        "outcome": "Swimming three mornings a week in calm water inside the reef with a friend, after cardiac rehabilitation",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic activity goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "LDL cholesterol below 70 mg/dL",
        "status": "completed",
        "target_date": "2026-04-27",
        "outcome": "LDL 62 mg/dL on atorvastatin 80 mg",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid goal.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Culturally safe care: address him as Mr. Kahanamoku, as he asked; take time; explain each test and medicine plainly; involve his ʻohana as he chooses while he makes the decisions",
        "status": "completed",
        "guideline_ids": [
          "GL-KEOLAMAMO",
          "GL-NH-HF-2015"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic care approach.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Heart failure cardiology consultation on the day of the two-week visit, with an echocardiogram, to confirm the diagnosis and its cause and to plan guideline-directed medical therapy, ischemic evaluation and device decisions",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-HFREF-ECDP-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Furosemide 40 mg every morning for congestion, with a daily weight and a written plan; metabolic panel and magnesium in one to two weeks; lower the dose when he is dry",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diuretic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Baseline tests: ECG, chest X-ray, NT-proBNP, metabolic panel and magnesium, blood count, iron studies, TSH, hemoglobin A1c, lipids and ALT; echocardiogram at the two-week visit",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline workup.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Atorvastatin raised from 40 to 80 mg for LDL 92 mg/dL; lipid panel in four to twelve weeks; goal below 70 mg/dL",
        "status": "completed",
        "guideline_ids": [
          "GL-CCD-2023",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Sodium: less salted and dried fish, shoyu and salty party food, using the foods he already eats; no routine fluid restriction; daily weights",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diet plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "Vaccinations: pneumococcal, influenza, COVID-19 and RSV as due, because heart disease raises the risk of severe respiratory infection",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-CDC-IMZ-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination plan.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-008",
        "display": "Native Hawaiian healing alongside clinic care, if he wishes: lomilomi through Ke Ola Mamo, a Native Hawaiian Health Care System; he will tell the clinic before using any plant medicine so that interactions can be checked; the clinic asks nothing further about his practices",
        "status": "completed",
        "guideline_ids": [
          "GL-KEOLAMAMO"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic plan; no practice or ceremony is described.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        }
      },
      {
        "id": "INT-009",
        "display": "Guideline-directed medical therapy: stop lisinopril and start sacubitril-valsartan 24/26 mg twice daily 36 hours after the last dose; change metoprolol tartrate to carvedilol 3.125 mg twice daily; empagliflozin 10 mg daily; add spironolactone when potassium and kidney function allow; raise one medicine every two weeks toward target doses, with a metabolic panel one to two weeks after each change",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-HFREF-ECDP-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GDMT plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-03-30"
      },
      {
        "id": "INT-010",
        "display": "Intravenous ferric carboxymaltose 750 mg at the two-week visit and again two weeks later, for iron deficiency in heart failure with reduced ejection fraction; iron studies again at about six months",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic iron plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-03-30"
      },
      {
        "id": "INT-011",
        "display": "Invasive coronary angiography within two weeks to define the coronary disease and whether revascularization could help",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-CCD-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ischemic evaluation decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-03-30"
      },
      {
        "id": "INT-012",
        "display": "Defibrillator decision: repeat echocardiogram after at least 90 days of optimized therapy; a primary-prevention ICD if the ejection fraction stays at 35% or below with NYHA class II to III",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-VA-ICD-2017",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic device plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-03-30"
      },
      {
        "id": "INT-013",
        "display": "Sick-day rules: on days of vomiting, diarrhea or not drinking, hold empagliflozin, furosemide, spironolactone and sacubitril-valsartan, keep carvedilol if blood pressure allows, drink small amounts often, and restart when eating and drinking normally for a day; a written card",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-HFREF-ECDP-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic plan decided at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-04-22"
      },
      {
        "id": "INT-014",
        "display": "Cardiac rehabilitation for heart failure, 36 sessions, adapted to an ocean athlete: pool swimming in the program, then calm water inside the reef with a companion and near a lifeguard, no breath-hold diving, no big surf until cleared, water through the morning, and out of the water at once for chest pain, lightheadedness or unusual breathlessness",
        "status": "completed",
        "guideline_ids": [
          "GL-HF-2022",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic rehabilitation and ocean-safety plan decided at the fourth visit.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-04-27"
      },
      {
        "id": "INT-015",
        "display": "Laboratory tests drawn at the clinic on the day of each medicine change or by the clinic's nurse at home, with nurse calls to titrate doses between visits",
        "status": "completed",
        "guideline_ids": [
          "GL-HFREF-ECDP-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic access plan decided after a missed laboratory check.",
          "author": "The Human Record generator",
          "created": "2026-11-06T12:00:00-05:00"
        },
        "recorded_date": "2026-09-28"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-HF-2022",
        "title": "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure",
        "publisher": "American Heart Association, American College of Cardiology, and Heart Failure Society of America (Circulation 2022;145(18):e895-e1032)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35363499/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-HFREF-ECDP-2024",
        "title": "2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction",
        "publisher": "American College of Cardiology (J Am Coll Cardiol 2024;83(15):1444-1488)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38466244/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-VA-ICD-2017",
        "title": "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death",
        "publisher": "American Heart Association, American College of Cardiology, and Heart Rhythm Society (Circulation 2018;138(13):e272-e391)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29084731/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-CCD-2023",
        "title": "2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease",
        "publisher": "American Heart Association and American College of Cardiology (Circulation 2023;148(9):e9-e119)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37471501/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, heart failure and ischemic heart disease monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-NH-HF-2015",
        "title": "Potentially Preventable Hospitalizations for Congestive Heart Failure Among Asian Americans and Pacific Islanders in Hawaiʻi",
        "publisher": "Journal of Immigrant and Minority Health 2015;17(5):1289-1297",
        "url": "https://pubmed.ncbi.nlm.nih.gov/25204624/",
        "version_or_year": "2015"
      },
      {
        "guideline_id": "GL-KEOLAMAMO",
        "title": "Ke Ola Mamo: a Native Hawaiian Health Care System serving Oʻahu (medical care, lomilomi and community health workers)",
        "publisher": "Ke Ola Mamo",
        "url": "https://keolamamo.org/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-AWV-CMS",
        "title": "Medicare Wellness Visits (Medicare Learning Network)",
        "publisher": "Centers for Medicare & Medicaid Services",
        "url": "https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/preventive-services/medicare-wellness-visits.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-PROSTATE-2018",
        "title": "Prostate Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-AAA-2019",
        "title": "Abdominal Aortic Aneurysm: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/abdominal-aortic-aneurysm-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-FALLS-2024",
        "title": "Falls Prevention in Community-Dwelling Older Adults: Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-community-dwelling-older-adults-interventions",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the 36-hour washout from lisinopril to sacubitril-valsartan, the change from metoprolol tartrate to carvedilol, the order of titration, spironolactone with an eGFR above 30 and potassium below 5.0, the sick-day holds when potassium reached 5.5, the missed laboratory check after the last dose increases, intravenous iron at a ferritin of 62, angiography without revascularization, the decision against an ICD at an ejection fraction of 38%, and the ocean-safety plan."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Sources: PBS American Masters, two Honolulu Star-Advertiser articles of 2018, Olympedia, EBSCO, the International Swimming Hall of Fame and the Encyclopedia of World Biography. The Hawaiʻi State Archives, the Bishop Museum, olympics.com, the New York Times obituary and David Davis's biography Waterman were not read; a 1962 wire report found through Papers Past could not be fetched. The heart attack is dated 1952, not 1955."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "His Native Hawaiian identity is described as he would describe it, without stereotype; his own healing practices are respected and not described. Mood screening is synthetic and negative. His wife appears only in a documented claim, and no relative or other real person is given a modern statement, decision or health fact."
    }
  }
}
